Genolution Inc.
Research Genolution Inc. (225220.KQ) on Bullrun: market cap KRW 26.74B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker225220.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 26.74B
- Financial periodQ2 2026
- RevenueKRW 3.09B
- Net incomeKRW 775.31M
- Free cash flow-KRW 797.18M
- Gross margin35.1%
Valuation Snapshot
latest market cap is KRW 26.74B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 26.74B | n/a | n/a | n/a |
About Genolution Inc.
Genolution Inc. manufactures and sells IVD medical instruments in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and double-stranded RNA (dsRNA) synthesis technology. The company offers Nextractor NX-Duo, Nextractor NX-32N/45N, Nextractor NX-Jr, Nextractor NX-24SA, NGS library preparation equipment, DNA/RNA extraction kits. It also develops and manufactures instruments and reagents for DNA/RNA;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Genolution Inc.'s market cap?
Genolution Inc.'s market capitalization is KRW 26.74B.
What does Genolution Inc. do?
Genolution Inc. manufactures and sells IVD medical instruments in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and double-stranded RNA (dsRNA) synthesis technology. The company offers Nextractor NX-Duo, Nextractor NX-32N/45N, Nextractor NX-Jr, Nextractor NX-24SA, NGS library preparation equipment, DNA/RNA extraction kits. It also develops and manufactures instruments and reagents for DNA/RNA; provides long dsRNA synthesis services; and siRNA/miRNA/shRNA synthesis service and related products.